Trial
NCT05567770
ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
Convergent Therapeutics, Inc.
Condition
Prostate Cancer Metastatic
Intervention
Actinium-J591
Why stopped
Stakeholder elected not to proceed with the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-24